Teva Pharmaceuticals (NYSE:TEVA) has joined with Direct Relief and the National Association of Free and Charitable Clinics (NAFC) in unveiling a second round of grant funding in the amount of $75,000 to each of 11 free and charitable clinics across Alabama, Mississippi, and Texas.
Originally launched in 2022 with an initial $2-million funding, in 2024, Teva committed an additional $2 million to support behavioral health services at selected free and charitable clinics for 2025 and 2026.
During 2025, these grantee programs reached more than 57,000 people with mental health services and conducted nearly 6,000 screenings for depression and anxiety, demonstrating significant impact in expanding access to behavioral health care for uninsured and underserved populations. Now in its fourth year, Community Routes: Access to Mental Health Care continues to address the critical need for expanded mental health services in medically underserved communities.
"At Teva, we're driven by the conviction that everyone deserves access to a healthy future. These clinics have shown that integrating mental health services into trusted primary care settings is both effective and essential for reaching people who otherwise have nowhere to turn," said Carol Richardson, Sustainability and Health Equity Lead, Teva U.S.
"Motivated by deep compassion for people living with mental health conditions, supporting patients, their families and these clinics through this grant reflects Teva’s purpose in practice.”
TEVA shares took on 25 cents to $31.40.
Related Stories
